CGTX

Cognition Therapeutics Inc
1.91
0.00 (0.00%)

Cognition Therapeutics Inc. (CGTX) Fundamentals

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
SHARE INFORMATION
Market Cap$ 55,369,890
Shares Outstanding28,989,471
Float21,850,198
Percent Float75.37%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.13
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months626,456
Institutional Holdings Percent22.2%
Institutional Sold Previous 3 Months390,478
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months3,208,628
Insider Holdings Percent0.3
Insider Sold Previous 3 Months-
Insider Shares Owned85,072
TRADING INFO
52 Week High$ 6.27
52 Week Low$ 1.07
52 Week High Change$ -53.53
21 Day Moving Average$ 2.0255
21 Day Extended Moving Average$ 2.0324
50 Day Moving Average$ 2.2917
50 Day Extended Moving Average$ 2.0913
200 Day Moving Average$ 2.144
200 Day Extended Moving Average$ 2.7692
10 Day Average Volume67,595
20 Day Average Volume65,198
30 Day Average Volume64,422
50 Day Average Volume164,755
Alpha-0.067954
Beta1.4414
Standard Deviation0.320422
R20.081792
7 Day Price Change$ -0.01
7 Day Percent Change-0.52%
21 Day Price Change$ -0.09
21 Day Percent Change-4.5%
30 Day Price Change$ -0.35
30 Day Percent Change-15.49%
Month to Date Price Change$ -0.06
Month to Date Percent Change-3.05%
Quarter to Date Price Change$ -0.19
Quarter to Date Percent Change-9.05%
180 Day Price Change$ -0.86
180 Day Percent Change-31.05%
200 Day Price Change$ -0.21
200 Day Percent Change-9.91%
Year to Date Price Change$ -0.19
Year to Date Percent Change-9.05%

Cognition Therapeutics Inc. (CGTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.40
Total Debt To Equity0.00
Int Coverage-1,384.50
Current Ratio4.20
Leverage Ratio1.30
Quick Ratio4.10
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 10,346,573
Price to Sales0.00
Price to Free Cash-6.60
PE High Last 5 Years0.00
Price To Book1.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-70.98
Return on Equity100.26
Return on Capital-35.32

Cognition Therapeutics Inc. (CGTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOLisa Ricciardi
Emplyoees21
Last AuditUQ
CIK0001455365
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2500 Westchester Avenue
Purchase, NY 10577
Websitehttps://www.cogrx.com
Facsimile-
Telephone+1 412 481-2210
Email-


Your Recent History
NASDAQ
CGTX
Cognition ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.